HENWOOD GERALDINE 4
4 · Recro Pharma, Inc. · Filed Apr 15, 2021
Insider Transaction Report
Form 4
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
- Award
Stock Options (Right to Buy)
2021-04-13+20,000→ 20,000 totalExercise: $2.93Exp: 2031-04-13→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options will vest 3 equal installments on the first, second and third anniversaries of the grant date, subject to continued service on the board.